5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 10.04▲ | 10.03▲ | 10.01▲ | 10.01▲ | 10.03▲ |
MA10 | 10.02▲ | 10.01▲ | 10.01▲ | 10.01▲ | 9.89▲ |
MA20 | 10.01▲ | 10.01▲ | 9.99▲ | 10.01▲ | 9.72▲ |
MA50 | 10.02▲ | 10.02▲ | 10.01▲ | 9.75▲ | 9.51▲ |
MA100 | 9.94▲ | 9.92▲ | 9.90▲ | 9.68▲ | 9.02▲ |
MA200 | 9.87▲ | 9.72▲ | 9.69▲ | 9.56▲ | 9.10▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.009▲ | 0.007▲ | 0.004▲ | -0.011▼ | 0.038▲ |
RSI | 62.239▲ | 60.324▲ | 59.210▲ | 60.084▲ | 60.316▲ |
STOCH | 57.222 | 42.222 | 39.444 | 74.589 | 93.833▲ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -10.811▲ | -2.367▲ |
CCI | 181.921▲ | 213.206▲ | 271.388▲ | 131.547▲ | 100.453▲ |
Friday, June 06, 2025 04:00 AM
Vera Therapeutics (NASDAQ:VERA) fell ~32% in the premarket on Friday after late-stage trial data indicated that the company’s lead asset, atacicept, targeted at a kidney disorder called immunoglobulin ...
|
Monday, June 02, 2025 10:07 AM
Shares of Vera Therapeutics (NASDAQ:VERA) rose after the company said on Monday it achieved its main goal in a late-stage trial evaluating atacicept for treating immunoglobulin A nephropathy in adults ...
|
Monday, June 02, 2025 04:01 AM
Company to host conference call and webcast on June 9, 2025, at 8:00 a.m. ETSAN FRANCISCO and VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 10.065 | 10.08 | 10.06 | 10.08 | 16,651 |
13/06/25 | 9.97 | 10.04 | 9.97 | 9.99 | 42,400 |
12/06/25 | 9.95 | 10.08 | 9.95 | 10.04 | 77,100 |
11/06/25 | 10.02 | 10.02 | 9.95 | 9.96 | 51,800 |
10/06/25 | 10.00 | 10.02 | 10.00 | 10.00 | 44,587 |
09/06/25 | 10.04 | 10.04 | 9.98 | 10.01 | 34,324 |
06/06/25 | 10.03 | 10.06 | 9.98 | 9.98 | 51,500 |
05/06/25 | 10.05 | 10.09 | 9.75 | 9.97 | 121,745 |
04/06/25 | 10.00 | 10.07 | 10.00 | 10.01 | 52,300 |
03/06/25 | 10.01 | 10.06 | 9.98 | 10.01 | 40,000 |
|
|
||||
|
|
||||
|
|